Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: October 9, 2003
Reporting Period: Third Quarter of 2003
This filing serves as a current report announcing the results of operations for the third quarter of 2003. The detailed financial data is contained within a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 (Press Release).
The company discloses the use of the following non-GAAP financial measures in its reporting:
- Net earnings excluding one-time charges
- Diluted earnings per share excluding one-time charges
- Gross margin excluding one-time charges
- Sales excluding the impact of foreign exchange
Material Changes and Comparisons
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated press release (Exhibit 99.1) for year-over-year comparisons and trend analysis.
Guidance, Outlook, and Management Commentary
Management Commentary: Abbott Laboratories management states that the presentation of non-GAAP measures provides useful information for evaluating ongoing business performance by adjusting for unusual or unpredictable factors. These measures are also used internally to monitor business performance.
Investor Caution: Management explicitly cautions investors to consider these non-GAAP measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP.
Guidance and Risks: The filing text does not provide specific forward-looking guidance, risk factors, or details on contingencies beyond the general caution regarding non-GAAP measures.
Important Facts for Investor Verification
- Verify the specific GAAP and non-GAAP financial results in the press release (Exhibit 99.1) incorporated by reference.
- Confirm the magnitude of "one-time charges" excluded from the non-GAAP earnings and margin calculations.
- Assess the impact of foreign exchange on reported sales figures as noted in the non-GAAP adjustments.
- Review the full press release for any forward-looking statements or guidance not detailed in this 8-K summary.